All news

Grifols (NASDAQ:GRFS) Stock Rating Lowered by Zacks Research

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Zacks Research has downgraded Grifols (NASDAQ:GRFS) from a "hold" to a "strong sell" rating. Other firms, including Wall Street Zen and JPMorgan Chase & Co., have also issued "hold" or "sell" ratings and decreased price targets for the biotechnology company. Institutional investors have adjusted their positions in Grifols, with several increasing their holdings during recent quarters.

Read original source

GRFS company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.